Search results
Results From The WOW.Com Content Network
The pharmaceutical industry in Pakistan was estimated to be worth Rs. 748 billion (US$2.6 billion) in 2023, representing about 1% of the country's GDP. [ 1 ] The industry is largely import-dependent, with more than 90% of raw material being imported and only 12% of active pharmaceutical ingredients locally produced. [ 1 ]
According to the Economic complexity index, Pakistan is the 67th largest export economy in the world and the 106th most complex economy. [10] During the fiscal year 2015–16, Pakistan's exports stood at US$20.81 billion and imports at US$44.76 billion, resulting in a negative trade balance of US$23.96 billion.
Ripple Fragrances Pvt. Ltd. is the spatial fragrance division of the NR Group, manufacturing Functional & Aircare Lifestyle Products. Established in 2005. It is headed by Kiran Ranga. [11] Rangsons Marketing Services Pvt Ltd., established in 1993, is the marketing arm of NR Group. [citation needed] NR Foundation is the Corporate Social ...
OPKO Health's (OPK) subsidiary EirGen Pharma to develop and commercialize RAYALDEE in Greater China in collaboration with an affiliate of Nicoya Therapeutics.
In 2016, German Merck KGaA executed a binding contract to divest its shareholding in Pakistan to Martin Dow Ltd. [11] [12] [13] In 2016, in a €1.5 million deal, Martin Dow acquired the Laboratoires Salem (before 2010 Bristol-Myers Squibb ) pharmaceutical manufacturing facility in Meymac , France.
The company started its operations in Pakistan as Glaxo Laboratories Pakistan Ltd and was listed on the Karachi Stock Exchange in 1951. [3] GSK Pakistan equation was formed when Beecham, Glaxo Welcome and Smith Kline, all having a big name in the pharmaceutical market and that were separate entities before, merged in 2002. [4]
National Institute for Biotechnology and Genetic Engineering or NIBGE (Urdu: قومی ادارہَ برائے فنونِ حیاتیاتی و مہندسیِ امورِ تناسل) is one of the main biotechnology institutes operated by Pakistan Atomic Energy Commission (PAEC). [2] It is located in Faisalabad. [3]
Biotech Consortium India Limited (BCIL), New Delhi was incorporated as public limited company in 1990 under The Companies Act, 1956. [1] The consortium is promoted by the Department of Biotechnology , Government of India and financed by the All India Financial Institutions and some corporate sectors. [ 2 ]